PACIFIC Research Study


The PACIFIC Study is a clinical trial for a drug called LP352. This study will assess the safety and tolerability of this drug as well as examine changes in seizure frequency over the 90-day treatment period. The study plans to enroll approximately 50 participants with a variety of treatment-resistant seizures that fall into the category of DEEs. There is no cost to participate in this clinical study.

Additional Information:

View the PACIFIC Study Fact Sheet

Visit the PACIFIC Study Clinical Webpage 


The information here is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. The content provided is for informational purposes only. LGS Foundation is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options.

Updated 7/27/2023